Cloverfields Capital Group Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$3.02M |
| 2 |
Brookfield
BN
|
+$2.89M |
| 3 |
Cenovus Energy
CVE
|
+$1.11M |
| 4 |
US Bancorp
USB
|
+$900K |
| 5 |
Starbucks
SBUX
|
+$797K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lifestance Health
LFST
|
+$24.4M |
| 2 |
Shopify
SHOP
|
+$1.41M |
| 3 |
SGI
Somnigroup International
SGI
|
+$1.31M |
| 4 |
Shattuck Labs
STTK
|
+$1.23M |
| 5 |
CrowdStrike
CRWD
|
+$1.23M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 64.04% |
| 2 | Financials | 6.3% |
| 3 | Technology | 5.86% |
| 4 | Consumer Staples | 5.84% |
| 5 | Industrials | 4.77% |
Similar funds
Cloverfields Capital Group's Q3 2022 Portfolio in Review
As of Q3 2022, Cloverfields Capital Group held 76 positions worth $295M, down 9.8% from $328M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Cloverfields Capital Group withdrew a net $23.5M in Q3 2022, closing 4 positions and reducing 27 holdings. Its most notable exit was Lifestance Health, an estimated $24.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 64% of assets, down from 67% a quarter earlier, followed by Financials and Technology.
Against the trend, Cloverfields Capital Group opened a new position in Union Pacific worth $2.65M.
- Cloverfields Capital Group's largest Q3 2022 buy was Union Pacific: 13,629 shares worth $2.65M.
- Cloverfields Capital Group added most to Starbucks in Q3 2022, an estimated $797K increase.
- Cloverfields Capital Group's biggest Q3 2022 reduction was Shattuck Labs, cutting an estimated $1.23M.
- Cloverfields Capital Group fully exited Lifestance Health in Q3 2022, selling an estimated $24.4M.
- Cloverfields Capital Group's ten largest holdings make up 74% of its $295M portfolio in Q3 2022.
- Cloverfields Capital Group opened 6 new positions and closed 4 in Q3 2022.
- Cloverfields Capital Group's portfolio value fell 9.8% quarter-over-quarter to $295M.
Based on Cloverfields Capital Group's 13F filing for Q3 2022, filed 14 Nov 2022.